Regeneron Pharmaceuticals on Track for Largest Percent Decrease Since June 2023 — Data Talk
Regeneron Pharmaceuticals, Inc. (REGN) is currently at $1111.94, down $33.09 or 2.89%
--Would be lowest close since Aug. 7, 2024, when it closed at $1067.80
--On pace for largest percent decrease since June 27, 2023, when it fell 8.71%
--Currently down six of the past seven days
--Currently down two consecutive days; down 3.33% over this period
--Worst two day stretch since the two days ending Sept. 6, 2024, when it fell 4.06%
--Down 6.14% month-to-date; on pace for worst month since April 2024, when it fell 7.46%
--Up 26.6% year-to-date
--Down 7.47% from its all-time closing high of $1201.76 on Aug. 27, 2024
--Up 33.22% from 52 weeks ago (Sept. 25, 2023), when it closed at $834.64
--Down 7.47% from its 52-week closing high of $1201.76 on Aug. 27, 2024
--Up 43.44% from its 52-week closing low of $775.18 on Oct. 27, 2023
--Traded as low as $1097.00; lowest intraday level since Aug. 8, 2024, when it hit $1069.03
--Down 4.19% at today's intraday low; largest intraday percent decrease since June 28, 2023, when it fell as much as 4.37%
--Worst performer in the S&P 500 today
--Second worst performer in the Nasdaq 100 today
All data as of 12:52:18 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 23, 2024 13:09 ET (17:09 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks